CARGO Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Samsara BioCapital GP, LLC, was filed 03 Jun 2024.
CARGO Therapeutics, Inc.: what insiders have been doing
Every trade that managers of CARGO Therapeutics, Inc. disclose to SEC (Form 4) is tracked on this page. CARGO Therapeutics, Inc. has had no insider filing for more than a year; the last one goes back to 19 August 2025.
Looking back to 2023, when coverage begins, insiders filed 4 purchases and 6 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended December 2024 · cache
T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.
- 63,436 shares@ US$4.3839.6% of flowCommon StockSEC:0001610717-25-000297:1
- 57,345 shares@ US$4.37965.6% of flowCommon StockSEC:0001610717-25-000297:0
- 1,632 shares@ US$4.181.8% of flowCommon StockSEC:0001610717-25-000275:0
- 27,404 shares@ US$3.841528.7% of flowCommon StockSEC:0001610717-25-000121:0
- 72,500 shares0Common StockSEC:0001610717-25-000119:0
- 1,629 shares@ US$4.00371.8% of flowCommon StockSEC:0001610717-25-000096:0
- 200,000 shares0Common StockSEC:0001610717-25-000069:0
- 72,500 shares0Common StockSEC:0001610717-25-000071:0
- 60,000 shares0Common StockSEC:0001610717-25-000068:0
- 50,000 shares0Common StockSEC:0001610717-25-000070:0
- 1,600 shares@ US$25.286.0% of flowCommon StockSEC:0001610717-24-000491:1
- 7,166 shares@ US$25.0959.0% of flowCommon StockSEC:0001610717-24-000492:1
- 2,975 shares@ US$5.034.9% of flowCommon StockSEC:0001610717-24-000492:2
- 2,975 shares@ US$25.0324.3% of flowCommon StockSEC:0001610717-24-000492:3
- 7,166 shares@ US$5.03100.0% of flowCommon StockSEC:0001610717-24-000492:0
- 1,600 shares@ US$5.032.2% of flowCommon StockSEC:0001610717-24-000491:0
- 294,000 shares@ US$17.00100.0% of flowCommon StockSEC:0001415889-24-015250:0Canonical exit: 28 Aug 2024 (T+90)
- 1,842,499 sharesCommon stock, par value $0.001 per share ("Common Stock")SEC:0000902664-24-000237:0
- 666,666 shares@ US$15.0067.0% of flowCommon StockSEC:0001209191-23-055621:1Canonical exit: 12 Feb 2024 (T+90)
- 3,381,323 sharesCommon StockSEC:0001209191-23-055621:0
- 737,000 sharesCommon StockSEC:0000950170-23-064519:0
- 473,786 sharesCommon StockSEC:0000899243-23-020350:1
- 333,333 shares@ US$15.0050.0% of flowCommon StockSEC:0001062993-23-020811:1Canonical exit: 12 Feb 2024 (T+90)
- 1,333,333 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-23-020350:2Canonical exit: 12 Feb 2024 (T+90)
- 2,579,502 sharesCommon StockSEC:0001062993-23-020811:0
25 of 26 declarations
About CARGO Therapeutics, Inc.
CARGO Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment. It specializes in utilizing T cell technology to target tumors.
Written on 25 June 2026 from the filings and market data available that day. Live figures are in the blocks above.
The weekly insider digest, free
One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.